The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Ebolavirus Glycoprotein Structure and Mechanism of Entry
Open accessAbstract
Ebolavirus (EBOV) is a highly virulent pathogen capable of causing a severe hemorrhagic fever with 50-90% lethality. The EBOV glycoprotein (GP) is the only virally expressed protein on the virion surface and is critical for attachment to host cells and catalysis of membrane fusion. Hence, the EBOV GP is a critical component of vaccines as well as a target of neutralizing antibodies and inhibitors of attachment and fusion. The crystal structure of the Zaire ebolavirus GP in its trimeric, prefusion conformation (3 GP(1) plus 3 GP(2)) in complex with a neutralizing antibody fragment, derived from a human survivor of the 1995 Kikwit outbreak, was recently determined. This is the first near-complete structure of any filovirus glycoprotein. The overall molecular architecture of the Zaire ebolavirus GP and its role in viral entry and membrane fusion are discussed in this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,525
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Fruit bats as reservoirs of Ebola virus
Leroy, E. M., Kumulungui, B., Pourrut, X., Rouquet, P., Hassanin, A., Yaba, P., Délicat, A., Paweska, J. T., Gonzalez, J.-P., & Swanepoel, R. (2005) · Nature · doi:10.1038/438575a · Cited by 1,606
Structure of influenza haemagglutinin at the pH of membrane fusion
Bullough, P. A., Hughson, F. M., Skehel, J. J., & Wiley, D. C. (1994) · Nature · doi:10.1038/371037a0 · Cited by 1,564
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995) · Nature · doi:10.1038/375291a0 · Cited by 1,437
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Structure of the dengue virus envelope protein after membrane fusion
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2004) · Nature · doi:10.1038/nature02165 · Cited by 1,203
Harrison, S. C. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1456 · Cited by 1,190
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,052
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme
White, J. M., Delos, S. E., Brecher, M., & Schornberg, K. (2008) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230802058320 · Cited by 892
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., & Cunningham, J. M. (2005) · Science · doi:10.1126/science.1110656 · Cited by 826
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., & Saphire, E. O. (2008) · Nature · doi:10.1038/nature07082 · Cited by 736
Self-citationLive attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
Jones, S. M., Feldmann, H., Ströher, U., Geisbert, J. B., Fernando, L., Grolla, A., Klenk, H.-D., Sullivan, N. J., Volchkov, V. E., Fritz, E. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1258 · Cited by 687
Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management
Borio, L., Inglesby, T., Peters, C. J., Schmaljohn, A. L., Hughes, J. M., Jahrling, P. B., Ksiazek, T., Johnson, K. M., Meyerhoff, A., O'Toole, T., et al. (2002) · JAMA · doi:10.1001/jama.287.18.2391 · Cited by 672
C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans
Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L., & Delgado, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6841-6844.2002 · Cited by 652
Stieneke-Gröber, A., Vey, M., Angliker, H., Shaw, E., Thomas, G., Roberts, C., Klenk, H. D., & Garten, W. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05305.x · Cited by 643
Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
Towner, J. S., Sealy, T. K., Khristova, M. L., Albariño, C. G., Conlan, S., Reeder, S. A., Quan, P.-L., Lipkin, W. I., Downing, R., Tappero, J. W., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000212 · Cited by 599
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60
Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., & Garten, W. (1992) · Nature · doi:10.1038/360358a0 · Cited by 582
Herpes simplex virus: receptors and ligands for cell entry
Spear, P. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00389.x · Cited by 581
A system for functional analysis of Ebola virus glycoprotein
Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., & Kawaoka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14764 · Cited by 575
Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1
Heldwein, E. E., Lou, H., Bender, F. C., Cohen, G. H., Eisenberg, R. J., & Harrison, S. C. (2006) · Science · doi:10.1126/science.1126548 · Cited by 562
Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J., & Nichol, S. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3602 · Cited by 552
Processing of the Ebola virus glycoprotein by the proprotein convertase furin
Volchkov, V. E., Feldmann, H., Volchkova, V. A., & Klenk, H.-D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5762 · Cited by 497
Chen, J., Lee, K. H., Steinhauer, D. A., Stevens, D. J., Skehel, J. J., & Wiley, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81771-7 · Cited by 477
Epitopes Involved in Antibody-Mediated Protection from Ebola Virus
Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L., & Hart, M. K. (2000) · Science · doi:10.1126/science.287.5458.1664 · Cited by 459
Crystal Structure of the Low-pH Form of the Vesicular Stomatitis Virus Glycoprotein G
Roche, S., Bressanelli, S., Rey, F. A., & Gaudin, Y. (2006) · Science · doi:10.1126/science.1127683 · Cited by 435
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
Mupapa, K., Massamba, M., Kibadi, K., Kuvula, K., Bwaka, A., Kipasa, M., Colebunders, R., Muyembe‐Tamfum, J. J., & the International Scientific and Technical Committee (1999) · The Journal of Infectious Diseases · doi:10.1086/514298 · Cited by 420
Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation
Yin, H.-S., Wen, X., Paterson, R. G., Lamb, R. A., & Jardetzky, T. S. (2006) · Nature · doi:10.1038/nature04322 · Cited by 418
Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein
Schornberg, K., Matsuyama, S., Kabsch, K., Delos, S., Bouton, A., & White, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.4174-4178.2006 · Cited by 414
Nabel, G. J., Yang, Z., Duckers, H. J., Sullivan, N. J., Sanchez, A., & Nabel, E. G. (2000) · Nature Medicine · doi:10.1038/78645 · Cited by 413
Discovery of Swine as a Host for the Reston ebolavirus
Barrette, R. W., Metwally, S. A., Rowland, J. M., Xu, L., Zaki, S. R., Nichol, S. T., Rollin, P. E., Towner, J. S., Shieh, W.-J., Batten, B., et al. (2009) · Science · doi:10.1126/science.1172705 · Cited by 398
Weissenhorn, W., Carfí, A., Lee, K.-H., Skehel, J. J., & Wiley, D. C. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80159-8 · Cited by 391
VOLCHKOV, V. E., BECKER, S., VOLCHKOVA, V. A., TERNOVOJ, V. A., KOTOV, A. N., NETESOV, S. V., & KLENK, H.-D. (1995) · Virology · doi:10.1006/viro.1995.0052 · Cited by 375
Simmons, G., Reeves, J. D., Grogan, C. C., Vandenberghe, L. H., Baribaud, F., Whitbeck, J. C., Burke, E., Buchmeier, M. J., Soilleux, E. J., Riley, J. L., et al. (2003) · Virology · doi:10.1006/viro.2002.1730 · Cited by 369
Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein G
Roche, S., Rey, F. A., Gaudin, Y., & Bressanelli, S. (2007) · Science · doi:10.1126/science.1135710 · Cited by 364
Ksiazek, T. G., Rollin, P. E., Williams, A. J., Bressler, D. S., Martin, M. L., Swanepoel, R., Burt, F. J., Leman, P. A., Khan, A. S., Rowe, A. K., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514321 · Cited by 359
Wool-Lewis, R. J., & Bates, P. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3155-3160.1998 · Cited by 357
Structural basis of West Nile virus neutralization by a therapeutic antibody
Nybakken, G. E., Oliphant, T., Johnson, S., Burke, S., Diamond, M. S., & Fremont, D. H. (2005) · Nature · doi:10.1038/nature03956 · Cited by 352
Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases
Casadevall, A., & Scharff, M. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.150 · Cited by 318
Antiviral antibody responses: the two extremes of a wide spectrum
Hangartner, L., Zinkernagel, R. M., & Hengartner, H. (2006) · Nature Reviews Immunology · doi:10.1038/nri1783 · Cited by 314
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection
Maruyama, T., Rodriguez, L. L., Jahrling, P. B., Sanchez, A., Khan, A. S., Nichol, S. T., Peters, C. J., Parren, P. W. H. I., & Burton, D. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6024-6030.1999 · Cited by 293
Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses
Shimojima, M., Takada, A., Ebihara, H., Neumann, G., Fujioka, K., Irimura, T., Jones, S., Feldmann, H., & Kawaoka, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01157-06 · Cited by 292
Geisbert, T. W., Geisbert, J. B., Leung, A., Daddario-DiCaprio, K. M., Hensley, L. E., Grolla, A., & Feldmann, H. (2009) · Journal of Virology · doi:10.1128/jvi.00561-09 · Cited by 275
Jahrling, P. B., Geisbert, T. W., Geisbert, J. B., Swearengen, J. R., Bray, M., Jaax, N. K., Huggins, J. W., LeDuc, J. W., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514310 · Cited by 269
The antiviral activity of antibodies in vitro and in vivo
Parren, P. W. H. I., & Burton, D. R. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)77018-6 · Cited by 261
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution
Malashkevich, V. N., Schneider, B. J., McNally, M. L., Milhollen, M. A., Pang, J. X., & Kim, P. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2662 · Cited by 261
Structural basis of viral invasion: lessons from paramyxovirus F
Lamb, R. A., & Jardetzky, T. S. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.08.016 · Cited by 260
Covalent Modifications of the Ebola Virus Glycoprotein
Jeffers, S. A., Sanders, D. A., & Sanchez, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12463-12472.2002 · Cited by 253
Takada, A., Fujioka, K., Tsuiji, M., Morikawa, A., Higashi, N., Ebihara, H., Kobasa, D., Feldmann, H., Irimura, T., & Kawaoka, Y. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2943-2947.2004 · Cited by 251
Biochemical Analysis of the Secreted and Virion Glycoproteins of Ebola Virus
Sanchez, A., Yang, Z.-Y., Xu, L., Nabel, G. J., Crews, T., & Peters, C. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6442-6447.1998 · Cited by 235
Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
Oswald, W. B., Geisbert, T. W., Davis, K. J., Geisbert, J. B., Sullivan, N. J., Jahrling, P. B., Parren, P. W. H. I., & Burton, D. R. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030009 · Cited by 230
Parren, P. W. H. I., Geisbert, T. W., Maruyama, T., Jahrling, P. B., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6408-6412.2002 · Cited by 204
Cathepsin L Is Involved in Proteolytic Processing of the Hendra Virus Fusion Protein
Pager, C. T., & Dutch, R. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12714-12720.2005 · Cited by 201
Mechanism of Membrane Fusion by Viral Envelope Proteins
Harrison, S. C. (2005) · Advances in Virus Research · doi:10.1016/s0065-3527(05)64007-9 · Cited by 199
Effects of Ebola Virus Glycoproteins on Endothelial Cell Activation and Barrier Function
Wahl-Jensen, V. M., Afanasieva, T. A., Seebach, J., Ströher, U., Feldmann, H., & Schnittler, H.-J. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10442-10450.2005 · Cited by 195
Jahrling, P. B., Geisbert, J., Swearengen, J. R., Jaax, G. P., Lewis, T., Huggins, J. W., Schmidt, J. J., LeDuc, J. W., & Peters, C. J. (1996) · Imported Virus Infections · doi:10.1007/978-3-7091-7482-1_12 · Cited by 175
Proteolysis of the Ebola Virus Glycoproteins Enhances Virus Binding and Infectivity
Kaletsky, R. L., Simmons, G., & Bates, P. (2007) · Journal of Virology · doi:10.1128/jvi.01170-07 · Cited by 173
Ectodomain shedding of the glycoprotein GP of Ebola virus
Dolnik, O., Volchkova, V., Garten, W., Carbonnelle, C., Becker, S., Kahnt, J., Ströher, U., Klenk, H., & Volchkov, V. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600219 · Cited by 173
The Role of Histidine Residues in Low-pH-Mediated Viral Membrane Fusion
Kampmann, T., Mueller, D. S., Mark, A. E., Young, P. R., & Kobe, B. (2006) · Structure · doi:10.1016/j.str.2006.07.011 · Cited by 170
Ebola Hemorrhagic Fever and Pregnancy
Mupapa, K., Mukundu, W., Bwaka, M. A., Kipasa, M., De Roo, A., Kuvula, K., Kibadi, K., Massamba, M., Ndaberey, D., Colebunders, R., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514289 · Cited by 165
Comprehensive Analysis of Ebola Virus GP1 in Viral Entry
Manicassamy, B., Wang, J., Jiang, H., & Rong, L. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4793-4805.2005 · Cited by 155
Pager, C. T., Craft, W. W., Patch, J. R., & Dutch, R. (2006) · Virology · doi:10.1016/j.virol.2006.01.007 · Cited by 152
Dube, D., Brecher, M. B., Delos, S. E., Rose, S. C., Park, E. W., Schornberg, K. L., Kuhn, J. H., & White, J. M. (2009) · Journal of Virology · doi:10.1128/jvi.01956-08 · Cited by 146
Association of the Caveola Vesicular System with Cellular Entry by Filoviruses
Empig, C. J., & Goldsmith, M. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5266-5270.2002 · Cited by 138
Similar Structural Models of the Transmembrane Proteins of Ebola and Avian Sarcoma Viruses
Gallaher, W. R. (1996) · Cell · doi:10.1016/s0092-8674(00)81248-9 · Cited by 137
Gupta, M., Mahanty, S., Bray, M., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4649-4654.2001 · Cited by 136
Preparation and Use of Hyperimmune Serum for Prophylaxis and Therapy of Ebola Virus Infections
Зубавичене, Н. М., Sergeyev, N. N., Чепурнов, А. А., & Sv, N. (1999) · The Journal of Infectious Diseases · doi:10.1086/514294 · Cited by 130
Kuhn, J. H., Radoshitzky, S. R., Guth, A. C., Warfield, K. L., Li, W., Vincent, M. J., Towner, J. S., Nichol, S. T., Bavari, S., Choe, H., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601796200 · Cited by 128
Ebola Hemorrhagic Fever: Evaluation of Passive Immunotherapy in Nonhuman Primates
Jahrling, P. B., Geisbert, J. B., Swearengen, J. R., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/520587 · Cited by 124
Wool-Lewis, R. J., & Bates, P. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1419-1426.1999 · Cited by 120
Thoennes, S. R., Li, Z.-N., Lee, B.-J., Langley, W. A., Skehel, J. J., Russell, R. J. M., & Steinhauer, D. A. (2007) · Virology · doi:10.1016/j.virol.2007.08.035 · Cited by 117
Takada, A., Feldmann, H., Ströeher, U., Bray, M., Watanabe, S., Ito, H., McGregor, M. W., & Kawaoka, Y. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1069-1074.2003 · Cited by 114
Simmons, G., Rennekamp, A. J., Chai, N., Vandenberghe, L. H., Riley, J. L., & Bates, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13433-13438.2003 · Cited by 109
Volchkova, V. A., Feldmann, H., Klenk, H., et al. (1998) · Virology · doi:10.1006/viro.1998.9389 · Cited by 103
Recombinant Human Monoclonal Antibodies to Ebola Virus
Maruyama, T., Parren, P. W. H. I., Sanchez, A., Rensink, I., Rodríguez, L. L., Khan, A. S., Peters, C. J., & Burton, D. R. (1999) · The Journal of Infectious Diseases · doi:10.1086/514280 · Cited by 102
Domínguez‐Soto, Á., Aragoneses-Fenoll, L., Martín‐Gayo, E., Martínez‐Prats, L., Colmenares, M., Naranjo‐Gómez, M., Borràs, F. E., Muñoz, P., Zubiaur, M., Toribio, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-09-048058 · Cited by 97
Ebola Virus Glycoprotein 1: Identification of Residues Important for Binding and Postbinding Events
Brindley, M. A., Hughes, L. J., Ruiz, A. J., McCray, P. B., Sanchez, A., Sanders, D. A., & Maury, W. J. (2007) · Journal of Virology · doi:10.1128/jvi.02433-06 · Cited by 92
Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995: Determinants of Survival
Sadek, R., Khan, A. S., Stevens, G., Peters, C. J., & Ksiazek, T. G. (1999) · The Journal of Infectious Diseases · doi:10.1086/514311 · Cited by 90
Role of endocytosis and cathepsin-mediated activation in Nipah virus entry
Diederich, S., Thiel, L., & Maisner, A. (2008) · Virology · doi:10.1016/j.virol.2008.02.019 · Cited by 86
Sanchez, A. (2007) · The Journal of Infectious Diseases · doi:10.1086/520597 · Cited by 86
Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level
Alazard-Dany, N., Volchkova, V. A., Reynard, O., Carbonnelle, C., Dolnik, O., Ottmann, M., Khromykh, A. A., & Volchkov, V. E. (2006) · Journal of General Virology · doi:10.1099/vir.0.81361-0 · Cited by 84
Chan, S. Y., Ma, M. C., & Goldsmith, M. A. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-9-2155 · Cited by 79
Gramberg, T., Soilleux, E. J., Fisch, T., Lalor, P. F., Hofmann, H., Wheeldon, S., Cotterill, A., Wegele, A., Winkler, T., Adams, D., et al. (2008) · Virology · doi:10.1016/j.virol.2007.11.001 · Cited by 73
Lee, J. E., & Saphire, E. O. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.05.004 · Cited by 71
Self-citationNeumann, G., Geisbert, T. W., Ebihara, H., Geisbert, J. B., Daddario-DiCaprio, K. M., Feldmann, H., & Kawaoka, Y. (2007) · Journal of Virology · doi:10.1128/jvi.02486-06 · Cited by 67
Ebola sGP—The first viral glycoprotein shown to be C-mannosylated
Falzarano, D., Krokhin, O. V., Domselaar, G. V., Wolf, K., Seebach, J., Schnittler, H., & Feldmann, H. (2007) · Virology · doi:10.1016/j.virol.2007.06.015 · Cited by 64
Smith, J. G., Mothes, W., Blacklow, S. C., & Cunningham, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1403-1410.2004 · Cited by 60
Lee, J. E., Kuehne, A. I., Abelson, D. M., Fusco, M. L., Hart, M. K., & Saphire, E. O. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.10.017 · Cited by 54
Self-citationRequirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein
Francica, J. R., Matukonis, M. K., & Bates, P. F. (2008) · Virology · doi:10.1016/j.virol.2008.10.029 · Cited by 53
Towards a vaccine against Ebola virus
Geisbert, T., & Jahrling, P. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.6.777 · Cited by 51
de Freitas, M. S., Gaspar, L. P., Lorenzoni, M., Almeida, F. C. L., Tinoco, L. W., Almeida, M. S., Maia, L. F., Degrève, L., Valente, A. P., & Silva, J. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611864200 · Cited by 49
Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein
Gomara, M. J., Mora, P., Mingarro, I., & Nieva, J. L. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.006 · Cited by 32
The Positive Sense Single Stranded RNA Viruses
(2005) · Elsevier eBooks · doi:10.1016/b978-0-12-249951-7.50015-8 · Cited by 20
Cited by
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,303
Exploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 482
Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1
Wang, H., Shi, Y., Song, J., Qi, J., Lu, G., Yan, J., & Gao, G. F. (2016) · Cell · doi:10.1016/j.cell.2015.12.044 · Cited by 289
Algal and Cyanobacterial Lectins and Their Antimicrobial Properties
Fernández Romero, J. A., Paglini, M. G., Priano, C., Koroch, A., Rodríguez, Y., Sailer, J., & Teleshova, N. (2021) · Marine Drugs · doi:10.3390/md19120687 · Cited by 21
Metadata
- Authors
- Lee, J. E., & Saphire, E. O.
- Venue
- Future Virology
- Publisher
- Informa UK Limited
- Published
- 2009-11
- Volume
- 4
- Issue
- 6
- Pages
- 621-635
- ISSN
- 1746-0794 (ISSN-L)
- 1746-0808
- OpenAlex
- W2127440699
- Cited by
- 281
- References
- 96
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.